EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Early Childhood CASPR2 Autoimmunity with Prominent Autonomic Dysfunction: Diagnostic Challenges and Effective Immunotherapy

Charlotte Sophie Ehl, Sarah Danica Berger, Lena Meyer-Ruhnke, Lars Schlotawa, Matthias Kettwig, Jutta Gaertner, Lara Maleen Marten

Neuropediatrics · 19.11.2026

DOI: 10.1055/a-3006-7350 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuropediatrics, erschienen am 19.11.2026. Verfasst von Charlotte Sophie Ehl und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Center for Child and Adolescent Health, Partner site Göttingen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CASPR2-associated neurological diseases cover a broad clinical spectrum, with limbic encephalitis and Morvan syndrome representing the most characteristic autoimmune phenotypes. We report the case of a 2-year-old boy who presented with abdominal and generalized pain, refusal to eat or drink, weight loss, loss of mobility, and behavioral changes, including sleep disturbances. Further clinical evaluation revealed pharmacoresistant arterial hypertension and hyperhidrosis. Extensive diagnostic testing excluded infectious and toxic causes. CASPR2 antibodies were detected in both serum and cerebrospinal fluid. Initial therapy with corticosteroids and intravenous immunoglobulins resulted in only minimal clinical improvement. Significant clinical recovery was only achieved after escalation of immunotherapy with plasmapheresis and subsequent B-cell–depleting therapy with rituximab. At the most recent follow-up visit, seven months after the first rituximab infusion, the patient showed complete recovery without residual symptoms. This case underscores the diagnostic challenges of CASPR2-associated autoimmunity in early childhood and highlights the importance of early recognition of this rare but treatable disease.

Förderung

  • German Center for Child and Adolescent Health, Partner site Göttingen

Zitieren

APA

Ehl, C. S., Berger, S. D., Meyer-Ruhnke, L., Schlotawa, L., Kettwig, M., Gaertner, J., & Marten, L. M. (2026). Early Childhood CASPR2 Autoimmunity with Prominent Autonomic Dysfunction: Diagnostic Challenges and Effective Immunotherapy. Neuropediatrics. https://doi.org/10.1055/a-3006-7350

Vancouver

Ehl CS, Berger SD, Meyer-Ruhnke L, Schlotawa L, Kettwig M, Gaertner J, et al. Early Childhood CASPR2 Autoimmunity with Prominent Autonomic Dysfunction: Diagnostic Challenges and Effective Immunotherapy. Neuropediatrics. 2026. doi:10.1055/a-3006-7350

BibTeX
@article{Ehl2026,
  author = {Ehl, Charlotte Sophie and Berger, Sarah Danica and Meyer-Ruhnke, Lena and Schlotawa, Lars and Kettwig, Matthias and Gaertner, Jutta and Marten, Lara Maleen},
  title = {Early Childhood CASPR2 Autoimmunity with Prominent Autonomic Dysfunction: Diagnostic Challenges and Effective Immunotherapy},
  journal = {Neuropediatrics},
  year = {2026},
  doi = {10.1055/a-3006-7350}
}
Kostenlos starten →